Study Demonstrates Cost-Effectiveness of EndoPredict for Breast Cancer
The EndoPredict test is more than twice as cost-effective as Oncotype Dx for predicting a patient’s recurrence of breast cancer.
Read MoreSearch Results for: genetic testing
Quadrant Biosciences Receives Supplemental Grant for Autism Research
The study’s detailed information about protein-coding regions of the genome will help to identify biomarkers that will improve diagnosis, clinical care, and outcomes for individuals with autism spectrum disorder.
Read More
Inside Track: Expanding Consumer Genomic Testing
AMP President Victoria M. Pratt, PhD, discusses the association’s updated position statement on consumer genomic testing.
Read MorePartners Developing Whole-Transcriptome Sequencing Assay for mRNA Analysis
The assay will be used to identify eligible patients for the pivotal trial of a selective FGFR inhibitor that is being evaluated for the treatment of patients with non-central nervous system solid tumors that have a specific gene fusion.
Read More
Companion Diagnostic Helps to Identify Breast Cancer Candidates for Combination PI3K Inhibitor Therapy
Use of the combination therapy requires detection of the patient’s status by an FDA-approved test, following progression on or after an endocrine-based regimen.
Read More